Biotechnology Whitepapers
FierceBiotech’s selection of whitepapers contains case studies and research on business and technology issues affecting life sciences. If you would like to submit a whitepaper to the library, please contact our advertising team.
The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
The FDA Review Process: a Technical Look
Pharma is Moving to Digital & Social Media. Wake up!
The Cutting Edge of Chemistry
Central Nervous System (CNS) Compound Library from OTAVA
Otava Lead-Like Library
Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector
Biologically Active Molecules: Chemical Research, Development and Scale-up
Avoiding Post-Acquisition Product Sales Failures
When Post-Acquisition Product Sales Fail To Meet Expectations While mergers and acquisitions stalled in the wake of the global financial crisis and concerns over healthcare reform, activity has
Read more...The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
As detailed in the Physician Payments Sunshine Provisions (PPSP), all vendors within the healthcare industry that interact with providers must disclose all transfers of monetary value annually to the
Read more...Can a R&D Tax Credit Expand Investment in Product Development for Global Health?
Tax credits are used throughout the world to encourage investment in R&D, but are tax credits a good tool to stimulate more R&D for diseases of the poor? The Center for Global Health R&D
Read more...WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
Best Practices: ERP Vendor Reference-Checking
Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
